PYRIMIDINEDIONE COMPOUND AND USE THEREOF - WUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY

Title:

PYRIMIDINEDIONE COMPOUND AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2022/068929

Kind Code:

A1

Abstract:

A compound as represented by formula I that inhibits the activity of CD73, and a preparation method therefor and the use thereof in the preparation of a drug.

More Like This:

WO/2023/114733	KRAS MODULATORS AND USES THEREOF
JP4593881	Use of triazolopyrimidine derivatives as fungicides in material protection
JP4841429	Azaspiroalkane derivative as an inhibitor of metalloprotease

Inventors:

ZHANG XUEJUN (CN)
CHANG SHAOHUA (CN)
LI XUEQIANG (CN)
LIU YONG (CN)
WANG HONGQIANG (CN)
YE DABING (CN)
WANG YONGGANG (CN)
QIAN LINA (CN)
LIU LIFEI (CN)
ZHANG BO (CN)
YANG JUN (CN)
LI LIE (CN)

Application Number:

PCT/CN2021/122197

Publication Date:

April 07, 2022

Filing Date:

September 30, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

WUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY (CN)

International Classes:

C07D487/04; A61K31/5025; A61P35/00

Domestic Patent References:

WO2019168744A1	2019-09-06
WO2012005805A1	2012-01-12
WO2021222522A1	2021-11-04

Foreign References:

CN102781940A

2012-11-14

Attorney, Agent or Firm:

ZHIFAN & PARTNERS (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: OLT RECEIVER PARAMETER CONFIGURATION METHOD AND DEVICE, STORAGE MEDIUM AND ELECTRONIC DEVICE

Next Patent: BENZAMIDE COMPOUND AND USE THEREOF